A prescription for monitoring drugs

E Marshall. Science. 1980.

. 1980 Feb 22;207(4433):853-5.

doi: 10.1126/science.7355265.

No abstract available

Similar articles

Keeping prescription drugs safe and effective.
Bryan PA. Bryan PA. Am Fam Physician. 1974 Nov;10(5):189-93. Am Fam Physician. 1974. PMID: 4421343 No abstract available.
S 2697: a toxic prescription.
Dorsey R. Dorsey R. JAMA. 1976 Sep 13;236(11):1255-8. JAMA. 1976. PMID: 989069 No abstract available.
The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
Simmons HE. Simmons HE. Int J Health Serv. 1974 Winter;4(1):95-107. doi: 10.2190/TW4Q-WEDA-2Q7V-RHAH. Int J Health Serv. 1974. PMID: 4829901 No abstract available.
Patients' needs in drug development and regulation.
Wardell WM. Wardell WM. Ann N Y Acad Sci. 1981;368:187-202. doi: 10.1111/j.1749-6632.1981.tb15448.x. Ann N Y Acad Sci. 1981. PMID: 7020538 Review. No abstract available.
Postmarketing surveillance of new drugs: I. Review of objectives and methodology.
Wardell WM, Tsianco MC, Anavekar SN, Davis HT. Wardell WM, et al. J Clin Pharmacol. 1979 Feb-Mar;19(2-3):85-94. doi: 10.1002/j.1552-4604.1979.tb02464.x. J Clin Pharmacol. 1979. PMID: 370159 Review. No abstract available.